These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5466792)

  • 1. [Values of antiviral antibodies in the plasma of the patients with otorhinolaryngologic cancer].
    Takasu T; Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Jul; 73(7 Suppl):Suppl:1074-5. PubMed ID: 5466792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunology in cancerology laryngo-pharingeal].
    Clemente JM; López-Campos JL
    Rev Esp Otoneurooftalmol Neurocir; 1976; 34(198):65-82. PubMed ID: 996350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development in the Japan Society of Cancer Research of the Head and Neck Region in the last few years].
    Sakai T
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):550-2. PubMed ID: 5106696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological changes with prognostic significance in malignant pharyngo-laryngeal tumors].
    Suceava I; Simu G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):53-8. PubMed ID: 6454219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of various immunologic indicators in patients with laryngopharyngeal cancer before and after administration of T-activin].
    Nummaev GM; Drevnina NA
    Vestn Otorinolaringol; 1989; (1):67. PubMed ID: 2785312
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.
    Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G
    Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
    Ghoneum M; Gill G; Perry L
    Laryngoscope; 1986 Nov; 96(11):1300. PubMed ID: 3773632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on serum LDH and tissue LDH isozyme values in malignant tumors of the head and neck].
    Hashimoto K
    Nihon Jibiinkoka Gakkai Kaiho; 1968 Apr; 71(4):463-82. PubMed ID: 5693716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticancer chemotherapy apropos of bleomycin].
    Miyake H; Suzuki Y; Kunishige N
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):677-89. PubMed ID: 4123695
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies against laryngeal carcinomas. Preliminary report.
    Cortesina G; Cavallo GP; Macario M; Regina S; Prat M; Bussolati G
    G Batteriol Virol Immunol; 1985; 78(1-6):3-7. PubMed ID: 3915739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of immunoglobulin A in patients with oral and laryngeal malignancies].
    Michalski H; Storch H; Brandl R; Fritsche T
    Stomatol DDR; 1981 Jun; 31(6):413-9. PubMed ID: 6949376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oto-rhino-laryngologic manifestations during lymphoid leukemia].
    Haguenauer JP; Coeur P
    Ann Otolaryngol Chir Cervicofac; 1971; 88(1):77-83. PubMed ID: 5547952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical consideration of lung metastasis of head and neck tumors].
    Kawabe Y
    Jibiinkoka; 1968 Jun; 40(6):483-9. PubMed ID: 5750890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune functions in cancers of the upper respiratory and digestive tracts].
    Follézou JY; Bayssas M; Provost MA; Fridman WH; Dumont J; Point D; Brugère J
    Nouv Presse Med; 1978 Oct; 7(37):3368. PubMed ID: 733515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the computer system in the radiotherapy of head and neck cancer].
    Matsuura S
    Nihon Jibiinkoka Gakkai Kaiho; 1973 Jan; 76(1):21-38. PubMed ID: 4734906
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum immunoglobulin levels in patients with head and neck cancer].
    Güven O; Demiralp AS; Oztürk A; Yetiz F; Cengiz T
    Ankara Univ Hekim Fak Derg; 1987 Sep; 14(3):241-5. PubMed ID: 3507863
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological surveillance of otorhinolaryngological cancers].
    Bagarry D; Favre R; Imbert J; Jausseran M; Meyer G; D'Istria JC; Serafino X
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Dec; 23(10):852-9. PubMed ID: 4282092
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cancer of the otorhinolaryngologic area].
    Dumont PU
    Sem Ther; 1968 Mar; 44(3):135-8. PubMed ID: 5741340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiotherapy of maxillary, pharyngeal, and laryngeal cancer].
    Mazaki N
    Gan No Rinsho; 1987 Mar; Spec No():311-7. PubMed ID: 3599432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.